The state group BioCubaFarma acknowledges a 40% shortage of medicines in Cuba
The state Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma) recognized on Tuesday a 40% deficit in the basic list of medicines in Cuba. The president of the business group, Eduardo Martínez, explained